TheraGenetics is a personalised medicine diagnostics company that is developing and commercialising a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of CNS disorders; bringing the right medicine to the right patient.
- TheraGenetics
Appoints Dr. Heiner Dreismann as Chairman of the Board And Mr.
Robert Forrester as Director
London, UK, August 2007 - TheraGenetics Closes
£3M Series A Financing
London, UK, July 2007